Newsroom
News & press releases.
Announcements, product updates and analysis from Paxton-Digital. For long-form briefs, see Editorial Insights.
Daniel Strickland Is the Voice the Room Has Been Waiting For
Singer, guitarist and pianist Daniel Strickland blends country heart, roadhouse rock and faith-rooted songwriting across four independent singles. Meet Paxton-Digital’s first featured artist, then play Fit the Room, the Daniel Strickland Live…
Press release · October 10, 2026Paxton-Digital Puts Prognosis at the Center of Paxton Scout: IP, Market and Clinical Outlooks
Paxton Scout puts prognosis at its center — an IP and market outlook and a clinical outlook — plus a free patent term and exclusivity estimator.
Press release · September 30, 2026AI Infrastructure Is Becoming a Power-and-Token Business
The AI infrastructure race is moving beyond GPUs. Power, cooling, optics, regional factories, and contracted inference capacity are becoming the real operating system of the next cycle.
Healthcare M&A · November 1, 2026Private Equity’s Hospital Count Jumps to 561 as Massachusetts Reviews Select Medical’s Buyout After the Fact
A tracker counts 561 private equity-owned U.S. hospitals, up 114 since July, while Massachusetts reviews Select Medical's buyout months after it closed.
Healthcare M&A · October 31, 2026Viatris Opens Its $36.50-a-Share Tender for Pacira, Setting a Nov. 16 Deadline for the Non-Opioid Pain Deal
Viatris launched its cash tender for Pacira BioSciences, maker of Exparel and Zilretta. The terms, the deadline and what the $1.65 billion deal signals.
News · October 29, 2026Two $150 Million Biotech IPOs, One From Boston, Test the Fall Window
Parkinson's cell-therapy developer Aspen Neuroscience and Boston's Bambusa Therapeutics each seek about $150 million in Nasdaq IPOs this week.
Healthcare M&A · October 28, 2026Bon Secours Affiliate Agrees to Take Surgery Partners Private in $5.7 Billion Deal
HealthSpan Partners, a Bon Secours Mercy Health affiliate, will pay $23.50 a share for Surgery Partners as Bain Capital rolls its 39% stake.
News organisation · October 27, 202656 Hospital Deals and Counting: 2026 Has Already Passed All of Last Year
Kaufman Hall tallied 16 announced hospital deals in Q3 and 56 through September, topping 2025’s 15-year low of 46. Mega-mergers and joint ventures are driving it.
News · October 26, 2026Lycia’s $318 Million IPO Pops in Its Debut, Testing Wall Street’s Appetite for Protein Degraders
Lycia Therapeutics sold 17.6 million shares at $18, the top of its range, then jumped in its Nasdaq debut. What LYCA says about the 2026 IPO window.
News · October 26, 2026Open Enrollment 2027: Compare Two Health Plans on Total Yearly Cost
HealthCare.gov enrollment runs Nov. 1 to Jan. 15 and Massachusetts to Jan. 23. How to compare two plans on premiums, deductibles and the yearly cap.
Healthcare M&A · October 25, 2026Gilead Pays Up to $1.9 Billion for Vir’s T-Cell Engagers as Pharma Keeps Buying Oncology Pipelines
The license covers three solid-tumor programs with $90 million upfront. Agilent, Galderma and BlackRock's HPS also closed notable deals in a week with no new IPOs.
Healthcare M&A · October 24, 2026Rush and Endeavor Plan a 12-Hospital, $11 Billion Chicago System, Targeting an Early-2027 Close
The merger would pair Rush University System for Health's academic medicine with Endeavor Health's suburban footprint. It is the largest hospital combination announced this month.
News organisation · October 23, 2026Kaiser Permanente’s Risant Health Moves Into Oklahoma With a Deal for INTEGRIS Health
Oklahoma’s largest nonprofit system, with 20 hospitals and about 13,000 employees, would become Risant’s third system after Geisinger and Cone Health.
News · October 22, 2026Alcon Pays $550 Million for Neurotech and Its Approved Eye Cell Therapy
Alcon bought Neurotech for $550 million upfront plus milestones, adding Encelto, the only FDA-approved MacTel therapy. The terms, risks and signals.
News organisation · October 16, 2026Iambic’s $150M IPO Tests Appetite for AI-Built Cancer Drugs
Iambic Therapeutics priced its IPO at $16, raising $150 million, then closed up about 18% on debut. What the AI drug developer's valuation says about the field.
News organisation · October 15, 2026Rush and Endeavor Build a Nearly $11 Billion System on Razor-Thin Margins
Rush University System for Health and Endeavor Health plan to merge into a 12-hospital, nearly $11 billion academic system under the Rush name. Both run on margins near 1%. Paxton-Digital breaks down…
News organisation · October 14, 2026Two Biotechs, One Window: Iambic and Cambridge’s City Therapeutics Test the Fall IPO Market
AI drug designer Iambic and Cambridge RNAi developer City Therapeutics are seeking about $325 million combined at their midpoints on Nasdaq this week. The terms, the pipelines, what is confirmed, and what…
News organisation · October 13, 2026STERIS Pays $2.1 Billion to Make Surgery Safer, and Bets Big on the Operating Room’s Consumables
STERIS will pay $2.1 billion (about $1.8 billion net of tax benefits) for Xodus Medical, maker of the Pink Pad surgical positioning system, a roughly 55%-margin consumables business. Paxton-Digital breaks down the…
News organisation · October 12, 2026A $5.8 Billion Signal: Healthcare’s Deal Machine Is Moving Care Into the Home
CD&R and McKesson agree to take Option Care Health private in a $5.8 billion deal, as billions more flow into rare disease, radiopharma and telehealth and Oura shelves its IPO. What it…
News organisation · February 1, 2026Paxton-Digital Announces Venture Capital Fundraising Efforts and Public Market Readiness Initiative
MANCHESTER, ENGLAND — [January 30, 2026] — Paxton-Digital, a newly established technology platform focused on organizing, protecting, and structuring digital intellectual property rights (“IPR”) at scale, today announced that it has commenced…
Put it to work.
Scout and the connected tools are included with SCOUT Pro, an eligible Paxton-Digital plan. Projects and custom builds start with a conversation.